BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Industry Experience vs Degrees: How to Move Up the Ladder Without Higher Education

  Though advanced degrees are certainly helpful, they’re not always necessary to start and advance in a career in the life sciences. One just has to be willing to put in the work.

  February 15, 2023

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Business

  Alexis Borisy and Co. Raise $520M for New Model VC

  Curie.Bio launched this week with $520 million to take early startups from ground zero through Series A funding.

  February 15, 2023

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Business

  Replay, MD Anderson Team Up to Launch Oncology-Focused Product Company (Updated)

  Genome engineering company Replay and the MD Anderson Cancer Center have joined forces to launch Syena, an oncology product company.

  February 15, 2023

   · 

  2 min read

   · 

  Hayleigh Evans
• 

  Business

  Janssen Returns Phase I NASH Candidate to Arrowhead

  Arrowhead Pharmaceuticals has gained full rights to ARO-PNPLA3, formerly JNJ-75220795, the company announced Wednesday.

  February 15, 2023

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Business

  Biogen Expects Modest Leqembi Revenue as Aduhelm Takes Another Hit

  Biogen’s 2022 fourth-quarter and full-year report comes the day after an additional warning on the company’s first Alzheimer’s drug came to light.

  February 15, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• Ipsen, Université de Montréal and IRICoR broaden existing oncology partnership, with an exclusive license agreement and two new discovery-stage programs

  Ipsen, Université de Montréal and IRICoR announce that Ipsen has exercised its option to acquire exclusive rights to a pre-clinical stage program with potential oncology applications.

  February 15, 2023

   · 

  9 min read
• Deals

  Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million

  Emergent BioSolutions announced that it has entered into an agreement to sell its travel health business to Bavarian Nordic for a total value of up to $380 million, including potential future milestone payments.

  February 15, 2023

   · 

  6 min read
• Business

  NeoDynamics announces changes to the Board of Directors - February 15, 2023

  NeoDynamics announces that Jie Bao and Xiaojun Xu will step down from the Board of Directors as of 2023-02-14 based on a mutual agreement.

  February 15, 2023

   · 

  1 min read
• Business

  Medivir AB - Year-End Report January - December 2022

  Continued strong recruitment in the dose escalation part of the fostrox study.

  February 15, 2023

   · 

  6 min read
• Business

  NanoViricides Has Filed its Quarterly Report - Company has Begun Production of Coronavirus Drug for Clinical Trials

  NanoViricides, Inc., reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending December 31, 2022 with the Securities and Exchange Commission on Tuesday, February 14, 2023.

  February 15, 2023

   · 

  12 min read